Cargando…
Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway
BACKGROUND: 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD) has been reported to inhibit a variety of cancer cell lines. The purpose of this study was to investigate the effects of DMDD on 4T1 breast cancer cells and the effects of DMDD on 4T1 breast cancer in mice and its molecular mechanis...
Autores principales: | Zhou, Xing, Wu, Xingchun, Qin, Luhui, Lu, Shunyu, Zhang, Hongliang, Wei, Jinbin, Chen, Lixiu, Jiang, Luhui, Wu, Yani, Chen, Chunxia, Huang, Renbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369253/ https://www.ncbi.nlm.nih.gov/pubmed/32764871 http://dx.doi.org/10.2147/DDDT.S237699 |
Ejemplares similares
-
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione isolated from Averrhoa carambola L. root ameliorates diabetic nephropathy by inhibiting the TLR4/MyD88/NF-κB pathway
por: Lu, Shunyu, et al.
Publicado: (2019) -
2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione inhibits the growth and metastasis of breast carcinoma in mice
por: Chen, Chunxia, et al.
Publicado: (2017) -
2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis
por: Wang, Lihui, et al.
Publicado: (2021) -
Hypoglycaemic activity of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione in streptozotocin-induced diabetic mice through ameliorating metabolic function and regulating peroxisome proliferator-activated receptor γ
por: Kintoko, Kintoko, et al.
Publicado: (2016) -
Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation
por: Wang, Lihui, et al.
Publicado: (2021)